GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027

GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET FORECAST 2019-2027
Global Sleep Apnea Diagnostic And Therapeutic Market By Diagnostic And Therapeutic (diagnostic(polysomnography Device (psg), Sleep Apnea Screening Device, Actigraphy Monitoring Device, Respiratory Polygraph, Oximeter), Therapeutic(airway Clearance Systems, Adaptive Servo-ventilation Systems, Positive Airway Pressure (pap) Device, Oral Appliances, Oxygen Devices, Other Therapeutic)) By End-user (hospitals & Sleep Laboratories, Home Care Settings) By Geography.
The global sleep apnea diagnostic and therapeutic market is anticipated to generate revenue of $9,986 million by 2027 and will grow at an estimated CAGR of 6.72% between 2019 and 2027. Sleep apnea is a severe sleep ailment that decreases or stops the patient’s breathing patterns during sleep. The following factors primarily drive the sleep apnea diagnostic market:
- Increase in the incidence of obesity
- Increasing geriatric population
- Increase in the number of shift workers
- The rising prevalence of sleep apnea
- Technological advancements
To know more about this report, request a free sample copy
The important drivers increasing growth in the global sleep apnea diagnostic market are increasing geriatric population and increase in in many shift workers. Sleep apnea is extensively predominant in the aging populace and remains underdiagnosed owing to aspects like lack of cognizance amongst the individuals and non-specific presentation of the disease. A considerable percentage of shift workers develop shift work disorder, a circadian rhythm sleep disorder characterized by sleep apnea, because of working in shifts.
Sleep apnea diagnostic and therapeutic products are used extensively for various purposes. Polysomnography (PSG) is a conventional method used to study two types of sleep, namely rapid eye movement, and non-rapid eye movement. Actigraphy systems are used to monitor the sleep and wake patterns or circadian rhythms of patients. Polygraphy is an examination process that measures and records a patient’s respiratory, cardiovascular and electrodermal reactions. Oximeter comprises of oximeter, fingertip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. The airway clearance systems are flexible to use and can be easily transported from one place to another. A PAP device enables the flow of pressured air through the airways of the respiratory tract through a face mask which is attached to a tube and a machine. Oxygen therapy can be administered in multiple ways depending on the severity of the patient’s condition. Oxygen concentrators available in home and portable models are the most used form of therapy equipment, and these have replaced the conventional tanks.
The need for R&D efforts and low heat resistance are the major factors hindering the sleep apnea diagnostic market.
The global sleep apnea diagnostic and therapeutic market segments include diagnostic and therapeutic and end user.
Diagnostic and Therapeutic are segmented into:
- Diagnostics
- Polysomnography device (PSG)
- Clinical PSG device
- Ambulatory PSG device
- Sleep apnea screening device
- Actigraphy monitoring device
- Respiratory polygraph
- Oximeter
- Fingertip oximeter
- Handheld oximeter
- Wrist-worn oximeter
- Tabletop oximeter
- Polysomnography device (PSG)
- Therapeutics
- Airway clearance systems
- Adaptive servo-ventilation systems
- Positive airway pressure (pap) device
- Oral appliances
- Oxygen devices
- Other therapeutics
End-users are segmented into:
- Home care settings
- Hospitals & sleep laboratories
This report covered the present market conditions and the growth prospects of the global sleep apnea diagnostic market for 2019-2027 and considered the revenue generated through the sales of sleep apnea diagnostic and end-users to calculate the market size by considering 2018 as the base year.
Geographically, the global sleep apnea diagnostic and therapeutic market has been segmented on the basis of four major regions, which include:
- North America Sleep Apnea Diagnostic And Therapeutic Market : The United States & Canada
- Asia-Pacific Sleep Apnea Diagnostic And Therapeutic Market : China, India, Japan, Australia, South Korea & Rest of APAC
- Europe Sleep Apnea Diagnostic And Therapeutic Market : The United Kingdom, France, Germany, Italy, Spain & Rest of Europe
- Rest of World: Latin America & Middle East and Africa
The sleep apnea diagnostic and therapeutics market in North America is expected to hold the largest share by 2027 due to the possibilities of a rise in the number of incidences of sleep apnea and lack of patient awareness regarding the disease and also the presence of sophisticated healthcare infrastructure coupled with high healthcare expenditures and patient disposable incomes. North America sleep apnea diagnostic and therapeutic market constitutes approx. 45% share.
On the other hand, the Asia-Pacific market is anticipated to be the fastest-growing region for the sleep apnea diagnostic market. Asia-Pacific is experiencing a rapid shift toward the adoption of sedentary lifestyles and thus, increasing prevalence of sleep apnea has been observed in this region.
Japan is the largest market in the Asia Pacific region majorly on account of the presence of high healthcare expenditure and patient disposable incomes. Also, the increase in initiatives by health organizations to boost awareness among patients regarding sleep apnea and need of its diagnosis further contributes to the market growth.
The sleep apnea diagnostic market is segmented based on end-user which is sub-divided into home care settings and hospitals & sleep laboratories. Sleep labs are equipped with a bed as well as instruments that can help identify sleep hitches by monitoring eye movement, brain activity, snoring, heart rate, body movements, and other parameters. The home care settings are anticipated to grow at the fastest rate during the forecast period, owing to the shift in preference toward homecare among patients.
The major market players of the global Sleep Apnea diagnostic and therapeutic market are:
- Nihon Kohden Corporation
- GE Healthcare
- Cadwell
- Medtronic PLC
- Koninklijke Philips N.V. (Philips)
Company profiles covers analysis of important players. Nihon Kohden is involved in patient monitoring sleep assessment neurology. The company also manufactures, develops and distributes electronic medical equipment with subsidiaries in the U.S., Europe, and Asia. Koninklijke Philips N.V. (Philips) mainly provides products related to lifestyle, lighting, and healthcare businesses. They have more than 450 innovative products and services which include advanced molecular imaging, computed tomography, interventional x-ray, radiation oncology, and pathology.
Key Findings of the global sleep apnea diagnostic and therapeutic market:
- Polysomnography device (PSG) holds the largest market share in terms of the diagnostic market
- Hospital & sleep lab dominated the global sleep apnea diagnostics market
- Oral appliances are the fastest growing therapeutic
- RESEARCH SCOPE
- STUDY GOALS
- SCOPE OF THE MARKET STUDY
- WHO WILL FIND THIS REPORT USEFUL?
- STUDY AND FORECASTING YEARS
- RESEARCH METHODOLOGY
- SOURCES OF DATA
- SECONDARY DATA
- PRIMARY DATA
- TOP-DOWN APPROACH
- BOTTOM-UP APPROACH
- DATA TRIANGULATION
- SOURCES OF DATA
- EXECUTIVE SUMMARY
- MARKET SUMMARY
- KEY FINDINGS
- POLYSOMNOGRAPHY DEVICE (PSG) HOLDS THE LARGEST MARKET SHARE IN TERMS OF DIAGNOSTIC MARKET
- HOSPITAL & SLEEP LAB DOMINATED THE GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET
- ORAL APPLIANCES ARE THE FASTEST GROWING THERAPEUTIC
- MARKET DETERMINANTS
- MARKET SCOPE & DEFINITION
- MARKET DRIVERS
- INCREASE IN THE INCIDENCE OF OBESITY
- INCREASING GERIATRIC POPULATION
- INCREASE IN NUMBER OF SHIFT WORKERS
- RISING PREVALENCE OF SLEEP APNEA
- TECHNOLOGICAL ADVANCEMENTS
- MARKET RESTRAINTS
- HIGH COST OF SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC DEVICES
- LACK OF AWARENESS OF THE SLEEP APNEA DISORDER
- MARKET OPPORTUNITIES
- LUCRATIVE OPPORTUNITIES IN DEVELOPING ECONOMIES
- INCREASE IN THE DEVELOPMENT OF SLEEP MEDICATION TO REDUCE SIDE EFFECTS
- GROWING OCCURRENCE OF SLEEP APNEA IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
- MARKET CHALLENGES
- PATENT EXPIRATIONS
- DEARTH OF PATIENT COMPLIANCE
- MARKET BY DIAGNOSTIC AND THERAPEUTIC
- DIAGNOSTIC
- POLYSOMNOGRAPHY DEVICE (PSG)
- CLINICAL PSG DEVICE
- AMBULATORY PSG DEVICE
- SLEEP APNEA SCREENING DEVICE
- ACTIGRAPHY MONITORING DEVICE
- RESPIRATORY POLYGRAPH
- OXIMETER
- FINGERTIP OXIMETER
- HANDHELD OXIMETER
- WRIST-WORN OXIMETER
- TABLETOP OXIMETER
- THERAPEUTIC
- AIRWAY CLEARANCE SYSTEMS
- ADAPTIVE SERVO-VENTILATION SYSTEMS
- POSITIVE AIRWAY PRESSURE (PAP) DEVICE
- ORAL APPLIANCES
- OXYGEN DEVICES
- OTHER THERAPEUTIC
- POLYSOMNOGRAPHY DEVICE (PSG)
- DIAGNOSTIC
- MARKET BY END-USER
- HOSPITALS & SLEEP LABORATORIES
- HOME CARE SETTINGS
- KEY ANALYTICS
- PORTER’S FIVE FORCES MODEL
- THREAT OF NEW ENTRANTS
- THREAT OF SUBSTITUTE
- BARGAINING POWER OF BUYERS
- BARGAINING POWER OF SUPPLIERS
- THREAT OF COMPETITIVE RIVALRY
- REGULATORY FRAMEWORK
- PETL ANALYSIS
- MARKET TRENDS
- OPPORTUNITY MATRIX
- PORTER’S FIVE FORCES MODEL
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- EUROPE
- GERMANY
- FRANCE
- THE UNITED KINGDOM
- ITALY
- SPAIN
- REST OF EUROPE
- ASIA PACIFIC
- JAPAN
- CHINA
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- REST OF THE WORLD
- LATIN AMERICA
- MIDDLE EAST AND AFRICA
- NORTH AMERICA
- COMPETITIVE LANDSCAPE
- MARKET POSITION ANALYSIS
- COMPANY PROFILES
- BRAEBON MEDICAL CORPORATION
- CADWELL
- CAREFUSION (MERGED WITH BECTON DICKINSON)
- DRIVE DEVILBISS HEALTHCARE
- FISHER & PAYKEL HEALTHCARE
- GE HEALTHCARE
- INVACARE CORP.
- ITAMAR MEDICAL LTD.
- KONINKLIJKE PHILIPS N.V. (PHILIPS)
- MEDTRONIC PLC
- NIHON KOHDEN CORPORATION
- RESMED INC.
- SMITHS GROUP PLC (SMITHS MEDICAL)
- SOMNOMEDICS
- TELEFLEX
LIST OF TABLES
TABLE 1 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 2 PREVALENCE OF SLEEP APNEA BY REGION 2015
TABLE 3 PREVALENCE OF COPD BY REGION
TABLE 4 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 5 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY DIAGNOSTIC DEVICE 2019-2027 ($ MILLION)
TABLE 6 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 7 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 8 GLOBAL SLEEP APNEA SCREENING DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 9 GLOBAL ACTIGRAPHY MONITORING DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 10 GLOBAL RESPIRATORY POLYGRAPH MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 11 GLOBAL OXIMETER MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 12 GLOBAL OXIMETER MARKET BY TYPE 2019-2027 ($ MILLION)
TABLE 13 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY THERAPEUTIC DEVICE 2019-2027 ($ MILLION)
TABLE 14 GLOBAL AIRWAY CLEARANCE SYSTEMS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 15 GLOBAL ADAPTIVE SERVO-VENTILATION SYSTEMS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 16 GLOBAL POSITIVE AIRWAY PRESSURE (PAP) DEVICE MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 17 GLOBAL ORAL APPLIANCES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 18 GLOBAL OXYGEN DEVICES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 19 GLOBAL OTHER THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 20 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 21 GLOBAL HOSPITALS & SLEEP LABORATORIES MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 22 GLOBAL HOME CARE SETTINGS MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 23 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY REGION 2019-2027 ($ MILLION)
TABLE 24 NORTH AMERICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 25 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 26 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 27 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 28 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 29 EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 30 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 31 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 32 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 33 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 34 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 35 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 36 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 37 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 38 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 39 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 40 ASIA PACIFIC SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 41 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 42 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 43 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 44 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 45 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 46 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 47 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
TABLE 48 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
TABLE 49 REST OF THE WORLD SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY COUNTRY 2019-2027 ($ MILLION)
TABLE 50 SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC COMPANY MARKET POSITION ANALYSIS 2017
LIST OF FIGURES
FIGURE 1 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 2 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE 2018 & 2027 (%)
FIGURE 3 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY POLYSOMNOGRAPHY DEVICE (PSG) 2019-2027 ($ MILLION)
FIGURE 4 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY CLINICAL PSG DEVICE 2019-2027 ($ MILLION)
FIGURE 5 GLOBAL POLYSOMNOGRAPHY DEVICE (PSG) MARKET BY AMBULATORY PSG DEVICE 2019-2027 ($ MILLION)
FIGURE 6 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY SLEEP APNEA SCREENING DEVICE 2019-2027 ($ MILLION)
FIGURE 7 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY ACTIGRAPHY MONITORING DEVICE 2019-2027 ($ MILLION)
FIGURE 8 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY RESPIRATORY POLYGRAPH 2019-2027 ($ MILLION)
FIGURE 9 GLOBAL SLEEP APNEA DIAGNOSTIC MARKET BY OXIMETER 2019-2027 ($ MILLION)
FIGURE 10 GLOBAL OXIMETER MARKET BY FINGER TIP OXIMETER 2019-2027 ($ MILLION)
FIGURE 11 GLOBAL OXIMETER MARKET BY HANDHELD OXIMETER 2019-2027 ($ MILLION)
FIGURE 12 GLOBAL OXIMETER MARKET BY WRIST-WORN OXIMETER 2019-2027 ($ MILLION)
FIGURE 13 GLOBAL OXIMETER MARKET BY TABLETOP OXIMETER 2019-2027 ($ MILLION)
FIGURE 14 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY THERAPEUTIC 2018 & 2027 (%)
FIGURE 15 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY AIRWAY CLEARANCE SYSTEMS 2019-2027 ($ MILLION)
FIGURE 16 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY ADAPTIVE SERVO -VENTILATION SYSTEMS 2019-2027 ($ MILLION)
FIGURE 17 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY POSITIVE AIRWAY PRESSURE (PAP) DEVICE 2019-2027 ($ MILLION)
FIGURE 18 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY ORAL APPLIANCES 2019-2027 ($ MILLION)
FIGURE 19 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY OXYGEN DEVICES 2019-2027 ($ MILLION)
FIGURE 20 GLOBAL SLEEP APNEA THERAPEUTIC MARKET BY OTHER THERAPEUTIC 2019-2027 ($ MILLION)
FIGURE 21 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET SHARE BY END-USER 2018 & 2027 (%)
FIGURE 22 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOSPITALS & SLEEP LABORATORIES 2019-2027 ($ MILLION)
FIGURE 23 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY HOME CARE SETTINGS 2019-2027 ($ MILLION)
FIGURE 24 PORTER’S FIVE FORCE MODEL
FIGURE 25 GLOBAL SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET REGIONAL OUTLOOK 2018 & 2027 (%)
FIGURE 26 THE UNITED STATES SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 27 CANADA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 28 GERMANY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 29 FRANCE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 30 THE UNITED KINGDOM SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 31 ITALY SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 32 SPAIN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 33 REST OF EUROPE SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 34 JAPAN SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 35 CHINA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 36 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 37 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 38 AUSTRALIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET BY END-USER 2019-2027 ($ MILLION)
FIGURE 39 INDIA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 40 SOUTH KOREA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 41 REST OF ASIA PACIFIC SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 42 LATIN AMERICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
FIGURE 43 MIDDLE EAST AND AFRICA SLEEP APNEA DIAGNOSTIC AND THERAPEUTIC MARKET 2019-2027 ($ MILLION)
- MARKET BY DIAGNOSTIC AND THERAPEUTIC
- DIAGNOSTIC
- POLYSOMNOGRAPHY DEVICE (PSG)
- CLINICAL PSG DEVICE
- AMBULATORY PSG DEVICE
- SLEEP APNEA SCREENING DEVICE
- ACTIGRAPHY MONITORING DEVICE
- RESPIRATORY POLYGRAPH
- OXIMETER
- FINGERTIP OXIMETER
- HANDHELD OXIMETER
- WRIST-WORN OXIMETER
- TABLETOP OXIMETER
- THERAPEUTIC
- AIRWAY CLEARANCE SYSTEMS
- ADAPTIVE SERVO-VENTILATION SYSTEMS
- POSITIVE AIRWAY PRESSURE (PAP) DEVICE
- ORAL APPLIANCES
- OXYGEN DEVICES
- OTHER THERAPEUTIC
- POLYSOMNOGRAPHY DEVICE (PSG)
- DIAGNOSTIC
- MARKET BY END-USER
- HOSPITALS & SLEEP LABORATORIES
- HOME CARE SETTINGS
- GEOGRAPHICAL ANALYSIS
- NORTH AMERICA
- THE UNITED STATES
- CANADA
- EUROPE
- GERMANY
- FRANCE
- THE UNITED KINGDOM
- ITALY
- SPAIN
- REST OF EUROPE
- ASIA PACIFIC
- JAPAN
- CHINA
- AUSTRALIA
- INDIA
- SOUTH KOREA
- REST OF ASIA PACIFIC
- REST OF THE WORLD
- LATIN AMERICA
- MIDDLE EAST AND AFRICA
- NORTH AMERICA
To request a free sample copy of this report, please complete the form below :
We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.